A neurodegenerative perspective on mitochondrial optic neuropathies

Area of Science:

• Ophthalmology
• Neuroscience
• Genetics

Background:

• Mitochondrial optic neuropathies are a significant cause of vision impairment and blindness.
• These disorders stem from genetic defects in mitochondrial DNA (mtDNA) or nuclear genes, impacting mitochondrial function.
• Key examples include Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (DOA).

Purpose of the Study:

• To review the genetic basis and clinical features of mitochondrial optic neuropathies.
• To discuss the neuropathological hallmarks, including selective retinal ganglion cell (RGC) loss.
• To explore the broader implications of associated neurological complications and potential therapeutic strategies.

Main Methods:

• Literature review of genetic defects and clinical presentations.
• Analysis of neuropathological findings, focusing on RGC vulnerability.
• Discussion of current management and emerging therapeutic avenues.

Main Results:

• Identified genetic heterogeneity in mitochondrial optic neuropathies, involving both mtDNA and nuclear genes.
• Highlighted preferential loss of smaller RGCs in the papillomacular bundle, with relative sparing of melanopsin-containing RGCs.
• Observed additional neurological complications in some patients, indicating broader central nervous system vulnerability.

Conclusions:

• Mitochondrial optic neuropathies involve complex genetic factors and distinct patterns of RGC loss.
• Associated neurological "plus" phenotypes offer insights into shared neurodegenerative pathways.
• Advances in drug discovery and genetic manipulation hold promise for future disease-modifying treatments.